ArticleJournal of global health2026
Integrated genomic and clinical indicators for predicting foetal chromosomal abnormalities: development and validation of a nomogram model.
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Foetal chromosomal abnormalities are identified as one of the leading causes of adverse pregnancy outcome in pregnancies that are referred on suspicion of structural abnormalities in the foetus. While various types of genomic analyses can be carried out in order to determine prenatal risk factors, no single nomogram in existence combines these factors to provide the probability of chromosomal abnormalities in the foetus. Methods: This was a retrospective cohort analysis among pregnant women referred for possible foetal structural anomalies who received invasive prenatal diagnostic tests at two tertiary referral centres within Hebei Province. The study participants received uniform prenatal evaluation and genomic analysis that included non-invasive prenatal testing as well as copy number variation analysis. Foetal anomalies identified by ultrasound were re-evaluated by expert reviewers, with confirmed structural anomalies being candidate predictors. Predictors were assessed with multivariable logistic regression analysis. Performance of the models was assessed by the discrimination method, calibration with bootstrap resampling, decision curve analysis, and internal validation with repeated cross-validation. Results: Abnormal results from Down syndrome screening, non-invasive prenatal testing, copy number variation sequencing, the presence of foetal structural abnormalities confirmed by ultrasound, and high gravidity were found to be independently associated with foetal chromosomal abnormalities. The nomogram showed high discriminative power, as evidenced by the area under the curve in the receiver operating characteristic curve graph, which exceeded 0.90. Calibration plots demonstrated good agreement between predicted and observed risks. Results from decision curve analysis suggested significant clinical benefit over a broad range of threshold probabilities. Validation results confirmed the stability of the nomogram. Conclusions: The proposed nomogram incorporates genomic technologies into clinical and ultrasound indicators for the precise estimation of risk on an individual basis for foetal chromosomal abnormalities. This tool may support prenatal counselling and assist clinicians in optimising diagnostic decision-making in pregnancies with suspected foetal structural abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.